Article
Atlanta — Recent developments in melanocyte-specific immunohistochemical stains are again proving that this technology, along with the proper technique, can enhance sensitivity in differentiating malignant melanoma from nevi in diagnostic specimens as well as in the interpretation of Mohs margins, according to Dirk M. Elston, M.D., here at the American Society for Dermatologic Surgery — American College of Mohs Micrographic Surgery and Cutaneous Oncology combined annual meeting.